/uccs/dachmarke-png.png)
/uccs/uccs-fellows/img_20210903_184437_contentbild_hochformat.jpg)
Jorge Duque Escobar has a background in pharmacy. His research career began with a PhD in the Department of Clinical Pharmacology and Toxicology at the UKE, where he used molecular biology methods and animal models to investigate mechanisms relevant to the development of cardiovascular disease. After his PhD, his work was awarded the Niemann Innovation Prize for Pharmacy 2018 and a research fellowship for a postdoctoral position (FFM) at UKE. He then joined the Cardiovascular Systems Medicine and Molecular Translation group at the UCCS, combining epidemiological and clinical data with molecular biology approaches to improve the understanding of the molecular mechanisms behind hypertension and cardiovascular diseases. Since 2025, he leads the "Immunoregulation of Cardiometabolic Diseases" research group at the Institute of Cardiogenetics (Director: Prof. Dr. Tanja Zeller), UKSH, Lübeck. His goal is to advance understanding of the multifactorial factors contributing to cardiovascular diseases using state-of-the-art methods in the Cardiovascular-Kidney-Metabolic Syndrome axis.
/uccs/uccs_web_contentbild.png)